Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 5.0T | 5.6T | 6.7T | 5.5T |
Cost of revenue | 2.5T | 2.7T | 3.1T | 2.7T |
Gross profit | 2.5T | 2.9T | 3.6T | 2.8T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.5T | 1.6T | 1.9T | 1.6T |
Other operating expenses | -138.0B | -144.5B | -209.6B | -116.9B |
Operating income | 1.1T | 1.4T | 1.9T | 1.3T |
Non operating interest income | ||||
Income | 123.4B | 139.9B | 5.1B | 124.6B |
Expense | 140.8B | 145.4B | 155.3B | 142.7B |
Other income expense | -213.1B | -186.0B | -190.6B | -77.5B |
Pretax income | 848.0B | 1.2T | 1.7T | 1.2T |
Tax provision | 156.0B | 260.8B | 467.7B | 273.6B |
Net income | 692.0B | 943.5B | 1.2T | 884.4B |
Basic EPS | — | 0.2 | 0.3 | 0.2 |
Diluted EPS | — | 0.2 | 0.3 | 0.2 |
Basic average shares | — | 3.9T | 3.9T | 3.9T |
Diluted average shares | — | 3.9T | 3.9T | 3.9T |
EBITDA | 1.6T | 2.0T | 2.5T | 1.8T |
Net income from continuing op. | 692.0B | 943.5B | 1.2T | 884.4B |
Minority interests | -18.1B | -27.5B | -35.8B | -26.3B |
Preferred stock dividends | — | — | — | — |